Introduction
The BIH Clinical Incubator (CLIC) at the Berlin Institute of Health (BIH), Charité, is a dynamic platform designed to accelerate the development of Advanced and Personalized Therapies (APTs) by bridging the gap between cutting-edge biomedical research and real-world clinical application. With a focus on transforming innovative therapeutic concepts into viable clinical solutions, CLIC offers startups and research teams an optimal environment for de-risking projects and fast-tracking them toward clinical trials.
Mission
CLIC’s mission is to provide the tools, expertise, and collaborative space needed to drive the next generation of personalized medical solutions, particularly in APTs. By combining scientific rigor with entrepreneurial guidance, CLIC ensures that academic researchers, clinicians, and startup founders can transform promising innovations into therapies that have a tangible impact on patient care.
Who It Serves
CLIC is designed to serve entrepreneurs, early-stage startups, and academic research teams that are focused on pioneering new therapies. Whether it's startups developing cutting-edge biomedical technologies or researchers looking to advance their clinical studies, CLIC provides the infrastructure, mentorship, and regulatory support necessary for success. It is particularly suited for those working in regenerative medicine, oncology, and rare diseases, offering tailored services to help these teams navigate the complexities of clinical development.
